AMGEN INC — Director's Dealing 2020

Jun 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2020-06-17

Reporting Person: SUGAR RONALD D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-17	Common Stock	M	1000	$54.69	Acquired	16576	Direct
2020-06-17	Common Stock	S	1000	$228.54	Disposed	15576	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-17	Nqso (Right to Buy)	$54.69	M	1000	Disposed	2021-04-25	Common Stock (1000)	Direct

Footnotes

F1: The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.

F2: These shares include 1,913 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.